Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity.

Newhouse JH, Kho D, Rao QA, Starren J.

AJR Am J Roentgenol. 2008 Aug;191(2):376-82. doi: 10.2214/AJR.07.3280.

PMID:
18647905
2.

Contrast-induced nephropathy: contrast material not required?

Baumgarten DA, Ellis JH.

AJR Am J Roentgenol. 2008 Aug;191(2):383-6. doi: 10.2214/AJR.08.1310.

PMID:
18647906
3.

Metformin monitoring and change in serum creatinine levels in patients undergoing radiologic procedures involving administration of intravenous contrast media.

Parra D, Legreid AM, Beckey NP, Reyes S.

Pharmacotherapy. 2004 Aug;24(8):987-93. Erratum in: Pharmacotherapy. 2004 Oct;24(10):1489.

PMID:
15338847
4.

Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.

Uddin MA, Rabbani MA, Jafary FH, Bhatti MA, Islam M.

J Coll Physicians Surg Pak. 2005 Dec;15(12):791-4.

PMID:
16398973
5.

Bone morphogenic protein-7 serum level decreases significantly in patients with contrast-induced nephropathy.

Duranay M, Segall L, Sen N, Yilmaz FM, Cetin M, Isleyen A, Kanbay M, Covic A.

Int Urol Nephrol. 2011 Sep;43(3):807-12. doi: 10.1007/s11255-010-9871-z. Epub 2010 Nov 11.

PMID:
21069567
6.

Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?

Choyke PL, Cady J, DePollar SL, Austin H.

Tech Urol. 1998 Jun;4(2):65-9.

PMID:
9623618
7.

Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.

Cigarroa RG, Lange RA, Williams RH, Hillis LD.

Am J Med. 1989 Jun;86(6 Pt 1):649-52.

PMID:
2729314
8.

Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.

Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK.

Am J Kidney Dis. 2009 Oct;54(4):602-9. doi: 10.1053/j.ajkd.2009.03.024. Epub 2009 Jun 17.

PMID:
19535188
9.

Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy.

Chamsuddin AA, Kowalik KJ, Bjarnason H, Dietz CA, Rosenberg MS, Gomes MD, McDermott CM, Hunter DW.

AJR Am J Roentgenol. 2002 Sep;179(3):591-6. Erratum in: AJR Am J Roentgenol 2002 Dec;179(6):1645.

PMID:
12185025
10.

Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.

Huber W, Schipek C, Ilgmann K, Page M, Hennig M, Wacker A, Schweigart U, Lutilsky L, Valina C, Seyfarth M, Schömig A, Classen M.

Am J Cardiol. 2003 May 15;91(10):1157-62.

PMID:
12745095
11.

Nephropathy in critically Ill patients without preexisting renal disease.

Polena S, Yang S, Alam R, Gricius J, Gupta JR, Badalova N, Chuang P, Gintautas J, Conetta R.

Proc West Pharmacol Soc. 2005;48:134-5.

PMID:
16416679
12.

Failure to demonstrate contrast nephrotoxicity.

Heller CA, Knapp J, Halliday J, O'Connell D, Heller RF.

Med J Aust. 1991 Sep 2;155(5):329-32.

PMID:
1895978
13.

Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.

Herts BR, Schneider E, Obuchowski N, Poggio E, Jain A, Baker ME.

AJR Am J Roentgenol. 2009 Aug;193(2):494-500. doi: 10.2214/AJR.08.1908.

PMID:
19620448
14.

Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.

Ng CS, Shaw AD, Bell CS, Samuels JA.

AJR Am J Roentgenol. 2010 Aug;195(2):414-22. doi: 10.2214/AJR.09.4150.

PMID:
20651198
15.

Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures.

Briguori C, Colombo A, Airoldi F, Melzi G, Michev I, Carlino M, Montorfano M, Chieffo A, Bellanca R, Ricciardelli B.

Catheter Cardiovasc Interv. 2006 Feb;67(2):175-80.

PMID:
16400668
16.

Nephrotoxicity of high-dose gadolinium compared with iodinated contrast.

Prince MR, Arnoldus C, Frisoli JK.

J Magn Reson Imaging. 1996 Jan-Feb;6(1):162-6.

17.

Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency.

Hans SS, Hans BA, Dhillon R, Dmuchowski C, Glover J.

Am Surg. 1998 May;64(5):432-6.

PMID:
9585778
18.

Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging.

Josephson SA, Dillon WP, Smith WS.

Neurology. 2005 May 24;64(10):1805-6.

PMID:
15911820
19.

Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents.

Harris KG, Smith TP, Cragg AH, Lemke JH.

Radiology. 1991 Jun;179(3):849-52.

PMID:
2028004
20.

Risk for contrast-induced nephropathy in elderly trauma patients.

Finigan R, Pham J, Mendoza R, Lekawa M, Dolich M, Kong A, Bernal N, Lush S, Barrios C.

Am Surg. 2012 Oct;78(10):1114-7.

PMID:
23025953

Supplemental Content

Support Center